Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
This article was originally published in The Tan Sheet
Executive Summary
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.
You may also be interested in...
Central, Eastern Europe Lead OTC Growth On Sector’s Top Continent
Central and Eastern Europe continue to drive OTC sales growth on the continent, with even low-growth countries matching the best levels in Western Europe.
Sales & Earnings In Brief
Glaxo previews streamlined consumer unit
In Brief
C&D may cover costs by raising prices